Suppr超能文献

通过共研磨法制备用于改善呋塞米溶出度的固体分散体及其表征

Development and characterization of solid dispersion for dissolution improvement of furosemide by cogrinding method.

作者信息

Siahi-Shadbad Mohammad Reza, Ghanbarzadeh Saeed, Barzegar-Jalali Mohammad, Valizadeh Hadi, Taherpoor Alireza, Mohammadi Ghobad, Barzegar-Jalali Azim, Adibkia Khosro

机构信息

Drug Applied Research Center, Tabriz University of Medical Science, Tabriz, Iran. ; Faculty of Pharmacy, Tabriz University of Medical Science, Tabriz, Iran.

Faculty of Pharmacy, Tabriz University of Medical Science, Tabriz, Iran. ; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran. ; Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Adv Pharm Bull. 2014 Dec;4(4):391-9. doi: 10.5681/apb.2014.058. Epub 2014 Aug 10.

Abstract

PURPOSE

The purpose of this study was to prepare and characterize solid dispersion formulation of furosemide to enhance dissolution rate.

METHODS

Solid dispersions with different drug: carrier ratios were prepared by cogrinding method using crospovidone and microcrystalline cellulose as carrier. The physical state and interactions between the drug and carrier were characterized by Fourier transform infrared spectroscopic (FT-IR) and X ray diffraction (XRD).

RESULTS

Solid dispersions (especially with drug: Carrier ratio of 1:2) showed a higher dissolution rate than their respective physical mixture and pure furosemide. Dissolution rate in pH 5.8 was also higher than pH 1.2. The XRD analysis showed that crystalline form was changed to the amorphous state in the solid dispersions. FT-IR analysis did not show any physicochemical interactions in the solid dispersion formulations. Release kinetic of formulations were fitted best to the Weibull and Wagner log probability (linear kinetic) as well as suggested 2 and Gompertz (non-linear kinetic) models.

CONCLUSION

The dissolution properties of furosemide were improved with the use of hydrophilic carriers in solid dispersions due to change in the crystalline form of the drug and more intimate contact between drug and carriers which was dependent on the type and ratio of carrier as well as dissolution medium pH.

摘要

目的

本研究旨在制备速尿的固体分散体配方并对其进行表征,以提高溶解速率。

方法

采用交联聚维酮和微晶纤维素作为载体,通过共研磨法制备不同药物与载体比例的固体分散体。通过傅里叶变换红外光谱(FT-IR)和X射线衍射(XRD)对药物与载体之间的物理状态和相互作用进行表征。

结果

固体分散体(尤其是药物与载体比例为1:2时)的溶解速率高于其各自的物理混合物和纯速尿。在pH 5.8时的溶解速率也高于pH 1.2时。XRD分析表明,固体分散体中晶型转变为无定形状态。FT-IR分析未显示固体分散体配方中有任何物理化学相互作用。制剂的释放动力学最符合威布尔模型、瓦格纳对数概率(线性动力学)模型以及建议的二级模型和冈珀茨(非线性动力学)模型。

结论

由于药物晶型的改变以及药物与载体之间更紧密的接触,使用亲水性载体的固体分散体可改善速尿的溶解性能,这取决于载体的类型和比例以及溶解介质的pH值。

相似文献

1
Development and characterization of solid dispersion for dissolution improvement of furosemide by cogrinding method.
Adv Pharm Bull. 2014 Dec;4(4):391-9. doi: 10.5681/apb.2014.058. Epub 2014 Aug 10.
5
To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Colloids Surf B Biointerfaces. 2010 Mar 1;76(1):170-8. doi: 10.1016/j.colsurfb.2009.10.030. Epub 2009 Nov 11.
9
Furosemide - Soluplus® Solid Dispersion: Development and Characterization.
Recent Pat Drug Deliv Formul. 2017;11(3):211-220. doi: 10.2174/1872211311666171129120020.
10
Development and physicochemical characterization of sirolimus solid dispersions prepared by solvent evaporation method.
Adv Pharm Bull. 2014 Dec;4(4):369-74. doi: 10.5681/apb.2014.054. Epub 2014 Aug 10.

引用本文的文献

本文引用的文献

1
Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):799-813. doi: 10.1016/j.ejpb.2013.09.007. Epub 2013 Sep 18.
3
Solid-state dependent dissolution and oral bioavailability of piroxicam in rats.
Eur J Pharm Sci. 2013 Jan 23;48(1-2):47-54. doi: 10.1016/j.ejps.2012.10.005. Epub 2012 Oct 22.
4
pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
Eur J Pharm Biopharm. 2012 Oct;82(2):219-29. doi: 10.1016/j.ejpb.2012.07.014. Epub 2012 Aug 3.
6
Rational formulation development and in vitro assessment of SMEDDS for oral delivery of poorly water soluble drugs.
Eur J Pharm Sci. 2012 Aug 15;46(5):508-15. doi: 10.1016/j.ejps.2012.04.001. Epub 2012 Apr 10.
7
Applications of supercritical fluids to enhance the dissolution behaviors of Furosemide by generation of microparticles and solid dispersions.
Eur J Pharm Biopharm. 2012 May;81(1):131-41. doi: 10.1016/j.ejpb.2012.01.002. Epub 2012 Jan 17.
8
New oral solid dosage form for furosemide oral administration.
Eur J Pharm Biopharm. 2012 Apr;80(3):621-9. doi: 10.1016/j.ejpb.2011.12.011. Epub 2011 Dec 30.
9
Ibuprofen-phospholipid solid dispersions: improved dissolution and gastric tolerance.
Int J Pharm. 2012 Jan 17;422(1-2):290-4. doi: 10.1016/j.ijpharm.2011.11.011. Epub 2011 Nov 15.
10
Development and in-vivo assessment of the bioavailability of oridonin solid dispersions by the gas anti-solvent technique.
Int J Pharm. 2011 Jun 15;411(1-2):172-7. doi: 10.1016/j.ijpharm.2011.04.006. Epub 2011 Apr 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验